UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Cellectis is implementing good security practices.
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.
This report shows a preliminary security rating for Cellectis. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Email security refers to various cybersecurity measures to secure the access and content of an ...
Malware, or malicious software, is any program or file that harms a computer or its user. Common ...
Compare Cellectis's security performance with other companies